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between the 2 groups. A more recent RCT had sim-
ilar results when comparing FPANS with loratadine
and with combined therapy.4 This double-blinded
placebo-controlled trial, which included 600
patients, measured patient- and clinician-rated total
symptom scores, individual nasal symptom scores,
and overall evaluations after 7 and 14 days of thera-
py. Although the symptom scores for the FPANS
group were significantly lower than those in the
loratadine and placebo groups, no significant differ-
ence in scores was found between the FPANS and
combined groups. The results were the same for the
quality-of-life questionnaire scores. In an RCT of 106
patients, budesonide nasal spray’s efficacy was test-
ed against terfenadine alone and in combination; the
nasal steroid alone was more effective than the his-
tamine.5 Combining the 2 drugs yielded no signifi-
cant improvements.
The newer nasal steroids such as fluticasone may
be more effective because of their stronger affinities
to glucocorticoid receptors, but no clinical evidence
confirms this hypothesis.6
RECOMMENDATIONS FROM OTHERS The Joint
Task Force on Practice Parameters in Allergy, Asthma,
and Immunology recommends second-generation
oral antihistamines for first-line therapy, but notes that
nasal steroids are the most effective medication class
for controlling allergy symptoms.7 The task force
states that combination drug therapy may be tried. A
monograph from the American Academy of Family
Physicians notes the lack of consensus guidelines for
first-line therapy and recommends that treatment be
individualized.8 It states that combination therapy may
be tried if monotherapy fails.
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How effective are nasal steroids combined
with nonsedating antihistamines 
for seasonal allergic rhinitis?
EVIDENCE-BASED ANSWER For treating seasonal
allergic rhinitis, inhaled nasal corticosteroids are supe-
rior to nonsedating antihistamines (Grade of recom-
mendation: A, based on a large meta-analysis of ran-
domized controlled trials [RCTs]). Combining nasal
steroids and nonsedating antihistamines yields no
additional benefits (Grade of recommendation: A,
based on several RCTs). Unless patient preference lim-
its their use, nasal steroids should be first-line therapy.
EVIDENCE SUMMARY A meta-analysis of 16 RCTs
compared the efficacy of intranasal steroids and oral
antihistamines for alleviating nasal, eye, and global
allergy symptoms.1 Intranasal steroids were superior
to oral antihistamines for all patient-oriented nasal
symptom and global symptom ratings. Eye symptom
scores and adverse events were similar in each treat-
ment group.
Several large RCTs have addressed whether com-
bining the 2 classes of drugs would achieve greater
symptom control. Only 1 study2 found combination
therapy to be superior. This RCT compared
beclomethasone dipropionate with loratadine or
placebo daily in 154 patients.2 Total symptom scores
were better for the combination group mainly due
to improved relief from ocular symptoms.
Fluticasone propionate aqueous nasal spray
(FPANS) was evaluated alone and in combination
with cetirizine in a multicenter double-blind study of
454 patients.3 The mean symptom scores for nasal
and eye symptoms were not significantly different
TA B L E  
Intranasal steroids for treating allergic rhinitis
Drug Usual adult dosages Cost per month*
Beclomethasone dipropionate
Beconase AQ 2 sprays/nostril qd $44
Vancenase AQ 2 sprays/nostril qd $40
Budesonide
Rhinocort AQ 2 sprays/nostril bid $48
Flunisolide
Nasarel 2 sprays/nostril bid $44
Nasalide 2 sprays/nostril bid $46
Fluticasone propionate
Flonase 2 sprays/nostril qd $53
Mometasone furoate
Nasonex 2 sprays/nostril qd $56
Triamcinolone acetonide
Nasacort AQ 2 sprays/nostril qd $56
bid, twice a day; qd, every day.
*Red Book. Medical Economics Data, 2001.
